{'Year': '2018', 'Month': 'Nov'}
Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
A major challenge for effective pharmacotherapy in pain management is to provide the drug best suited to the patient's innate characteristics.